Publications by authors named "Mohamed S H Ramadan"

Objectives: Serous ovarian carcinoma (SOC) is a biologically heterogeneous with different genomic and molecular profiles, beside clinical response to the chemotherapy with subsequent in obstacles in starting unified, acceptable treatments and so we assess immunoexpression of Nanog, ZEB1, and EpCAM in SOC.

Methods: In this study, the immunoexpression of Nanog, ZEB1, and EpCAM was studied in 60 cases of SOC. Overall survival (OS), disease-free survival (DFS) data and response to chemotherapy were  analyzed.

View Article and Find Full Text PDF

Objective: To asses miR-379-5p expression in endometrial cancer (EC) and its correlation with ROR1 expression and to investigate the relation between miR-379-5p and ROR1 expressions and the clinicopathological picture of EC.

Methods: Fifty female of EC were joined to this study. The gene expression of miR-379-5p (by quantitative real time-PCR) and ROR1 (by quantitative real time-PCR and immunohistochemistry) were studied in EC and normal nearby endometrial tissue.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Mohamed S H Ramadan"

  • - Mohamed S H Ramadan's recent research focuses on the investigation of molecular biomarkers in cancer, particularly in serous ovarian carcinoma (SOC) and endometrial cancer (EC), to understand their prognostic roles.
  • - In his study on SOC, Ramadan assessed the immunoexpression of NANOG, ZEB1, and EpCAM in a cohort of 60 patients, revealing insights into their impact on overall and disease-free survival as well as chemotherapy response.
  • - His research on endometrial cancer explored the expression of miR-379-5p and its correlation with ROR1, utilizing techniques like quantitative real-time PCR, highlighting the potential interplay between these biomarkers and the clinical characteristics of EC.